GSK Adds Around $5B in a Month: Here's How to Play the Stock

Key Takeaways GSK gained 6.4% in a month, adding nearly $5B in market value despite slowing vaccine sales.Specialty Medicines rose 16% in H1 2025, with oncology and long-acting HIV drugs driving growth.GSK's R&D, pipeline approvals and upcoming launches bolster its long-term sales outlook.GSK (GSK) stock has risen 6.4% over the past month, adding nearly $5 billion to its market value.The consistently strong performance of the Specialty Medicines unit, regulatory and pipeline successes and an optimistic outl ...